Manuela Matta

619 total citations
16 papers, 203 citations indexed

About

Manuela Matta is a scholar working on Pathology and Forensic Medicine, Oncology and Plant Science. According to data from OpenAlex, Manuela Matta has authored 16 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Plant Science. Recurrent topics in Manuela Matta's work include Multiple Sclerosis Research Studies (9 papers), Polyomavirus and related diseases (4 papers) and Ophthalmology and Eye Disorders (4 papers). Manuela Matta is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Polyomavirus and related diseases (4 papers) and Ophthalmology and Eye Disorders (4 papers). Manuela Matta collaborates with scholars based in Italy, United States and Switzerland. Manuela Matta's co-authors include Alessandro Serra, Clara Grazia Chisari, Antonio Bertolotto, Alessia Di Sapio, Maria Malentacchi, Simona Malucchi, Marco Capobianco, Francesca Sperli, Marinella Clerico and Alessandro Maglione and has published in prestigious journals such as Neurology, Frontiers in Immunology and Nutrients.

In The Last Decade

Manuela Matta

15 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuela Matta Italy 8 126 45 44 36 35 16 203
Arabella Buchmann Austria 8 69 0.5× 68 1.5× 15 0.3× 13 0.4× 17 0.5× 14 180
Konstantinos Kilidireas Greece 6 88 0.7× 61 1.4× 16 0.4× 20 0.6× 5 0.1× 8 209
Silvia Messina Italy 11 190 1.5× 100 2.2× 21 0.5× 28 0.8× 3 0.1× 15 301
Stefan Macher Austria 11 52 0.4× 230 5.1× 10 0.2× 13 0.4× 52 1.5× 33 285
Mario Santangelo Italy 7 178 1.4× 102 2.3× 24 0.5× 31 0.9× 6 0.2× 19 294
Rasa Kizlaitienė Lithuania 6 125 1.0× 31 0.7× 14 0.3× 12 0.3× 8 0.2× 17 145
Dietrich Sturm Germany 9 75 0.6× 83 1.8× 14 0.3× 17 0.5× 67 1.9× 20 262
Elio Prestipino Italy 9 137 1.1× 60 1.3× 17 0.4× 17 0.5× 2 0.1× 15 196
Bernardita Soler Chile 8 59 0.5× 48 1.1× 6 0.1× 53 1.5× 4 0.1× 22 260
Lev Brylev Russia 9 37 0.3× 55 1.2× 10 0.2× 11 0.3× 4 0.1× 31 181

Countries citing papers authored by Manuela Matta

Since Specialization
Citations

This map shows the geographic impact of Manuela Matta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Matta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Matta more than expected).

Fields of papers citing papers by Manuela Matta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Matta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Matta. The network helps show where Manuela Matta may publish in the future.

Co-authorship network of co-authors of Manuela Matta

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Matta. A scholar is included among the top collaborators of Manuela Matta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Matta. Manuela Matta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fraisse, T., Virginie Prendki, Alain Putot, et al.. (2025). Prevention of aspiration pneumonia recurrences. Infectious Diseases Now. 55(6). 105102–105102.
3.
Maglione, Alessandro, et al.. (2023). Feeding the gut microbiome: impact on multiple sclerosis. Frontiers in Immunology. 14. 1176016–1176016. 22 indexed citations
4.
Maglione, Alessandro, Rachele Francese, Manuela Matta, et al.. (2023). Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis. Frontiers in Immunology. 14. 1205879–1205879. 3 indexed citations
5.
Miele, Giuseppina, Luigi Lavorgna, Stefania Federica De Mercanti, et al.. (2021). Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study. Neurological Sciences. 43(5). 3223–3229. 2 indexed citations
6.
Mercanti, Stefania Federica De, et al.. (2020). Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question. Journal of Investigative Medicine High Impact Case Reports. 8. 2737404954–2737404954. 2 indexed citations
7.
Mercanti, Stefania Federica De, et al.. (2019). D-dimer Increasing After First Alemtuzumab Administration in a Multiple Sclerosis Patient. Institutional Research Information System University of Turin (University of Turin). 5(5). 67–67. 2 indexed citations
8.
Serra, Alessandro, Clara Grazia Chisari, & Manuela Matta. (2018). Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment. Frontiers in Neurology. 9. 31–31. 51 indexed citations
9.
Sapio, Alessia Di, et al.. (2017). Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients. Multiple Sclerosis and Related Disorders. 14. 51–55. 19 indexed citations
10.
Jacobs, Jonathan B., Alessandro Serra, Clara Grazia Chisari, et al.. (2017). Evaluation of saccades show ocular-motor fatigue in internuclear ophthalmoparesis due to multiple sclerosis. 58(8). 755–755. 1 indexed citations
11.
Malucchi, Simona, Marco Capobianco, Maria Malentacchi, et al.. (2016). High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study. Neurology and Therapy. 6(1). 145–152. 23 indexed citations
12.
Bertolotto, Antonio, Letizia Granieri, Fabiana Marnetto, et al.. (2014). Biological monitoring of IFN-β therapy in Multiple Sclerosis. Cytokine & Growth Factor Reviews. 26(2). 241–248. 19 indexed citations
13.
Capobianco, Marco, Alessia Di Sapio, Simona Malucchi, et al.. (2014). Fingolimod is Not Able to Inhibit Multiple Sclerosis Disease Reactivation after Natalizumab Discontinuation (P7.206). Neurology. 82(10_supplement). 1 indexed citations
14.
Capobianco, Marco, Alessia Di Sapio, Maria Malentacchi, et al.. (2014). No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation. European Journal of Neurology. 22(3). 585–587. 20 indexed citations
15.
Matta, Manuela, R. John Leigh, Maura Pugliatti, I. Aiello, & Alessandro Serra. (2009). Using fast eye movements to study fatigue in multiple sclerosis. Neurology. 73(10). 798–804. 17 indexed citations
16.
Serra, Alessandro, Ke Liao, Manuela Matta, & Richard Leigh. (2008). Diagnosing disconjugate eye movements. Neurology. 71(15). 1167–1175. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026